AC Immune
Lausanne, Switzerland
Biotechnology
CEO: Andrea Pfeifer, 51
This company, co-founded by a Nobel Laureate in chemistry in 2003, is working on treatments for Alzheimer's disease. Alzheimer's is caused by abnormal aggregations of proteins, called plaques, that block normal brain functioning. AC Immune is developing therapies to dissolve the plaques and inhibit their formation. Clinical trials of three such treatments began this year.
Business Tools
A-Z Index
List & Rankings
Blogs
- Apple
- Asia
- Autos
- Branding
- Economy
- Investing
- Management Trends
- Real Estate
- Small Business
- Social Media
- Technology
